SCHEDULE 13D

Company

Decoy Therapeutics Inc.

Filed

October 27, 2023

Accession Number

0001099910-23-000188

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →